Group revenue dipped 0.8 percent to 59.6 billion euros.
Glaxo buys Bellus for US$2bn
Move after GSK demerged its consumer healthcare unit.
AstraZeneca 2022 profit $3.3bn
The firm's revenues rose to US$44.4 billion in 2022.
Pfizer to make $5bn acquisition
US drugmaker is in talks to buy Global Blood Therapeutics.Pfizer Covid pill sees demand
The drugmaker reported another round of strong earnings.
